ATE499611T1 - METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I - Google Patents

METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I

Info

Publication number
ATE499611T1
ATE499611T1 AT04764908T AT04764908T ATE499611T1 AT E499611 T1 ATE499611 T1 AT E499611T1 AT 04764908 T AT04764908 T AT 04764908T AT 04764908 T AT04764908 T AT 04764908T AT E499611 T1 ATE499611 T1 AT E499611T1
Authority
AT
Austria
Prior art keywords
diagnosis
diseases
apolipoprotein
determining
determining apolipoprotein
Prior art date
Application number
AT04764908T
Other languages
German (de)
Inventor
Andreas Bergmann
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Application granted granted Critical
Publication of ATE499611T1 publication Critical patent/ATE499611T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Diagnosis, early recognition, risk assessment and monitoring progression of diseases comprising determining, in a human serum or plasma sample, the content of apolipoprotein C-I (A) and/or its derivatives, is new. Disease is deduced if the measured value is significantly different from values in a healthy subject. An independent claim is also included for use of (A) to prepare an injectable composition for treatment of cancer and sepsis. ACTIVITY : Antibacterial; Immunosuppressive; Cytostatic. No biological data given. MECHANISM OF ACTION : None given.
AT04764908T 2003-09-22 2004-09-07 METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I ATE499611T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10343815A DE10343815A1 (en) 2003-09-22 2003-09-22 Diagnosis, particularly of cancer and sepsis, by determining abnormal contents of apolipoprotein C-I in serum or plasma, also therapeutic use of apolipoprotein C-I
PCT/EP2004/009965 WO2005038461A1 (en) 2003-09-22 2004-09-07 Method for the diagnosis of diseases by determining apolipoprotein ci

Publications (1)

Publication Number Publication Date
ATE499611T1 true ATE499611T1 (en) 2011-03-15

Family

ID=34306015

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04764908T ATE499611T1 (en) 2003-09-22 2004-09-07 METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I

Country Status (8)

Country Link
US (1) US20100159492A1 (en)
EP (1) EP1664789B1 (en)
JP (1) JP2007506075A (en)
CN (1) CN1856707A (en)
AT (1) ATE499611T1 (en)
DE (2) DE10343815A1 (en)
ES (1) ES2358903T3 (en)
WO (1) WO2005038461A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502227B1 (en) * 2005-08-08 2007-08-15 Vitateq Biotechnology Gmbh METHOD FOR DIAGNOSIS OF TUMORS
DE102006056337A1 (en) 2006-11-29 2008-06-05 B.R.A.H.M.S Ag In vitro diagnostic and early diagnosis of neurodegenerative diseases
JP5366234B2 (en) * 2007-08-24 2013-12-11 学校法人関西医科大学 Prognosis prediction method and prognosis prediction kit after radiation therapy for squamous cell carcinoma
KR101431062B1 (en) * 2012-03-08 2014-08-21 (주)바이오메디앙 Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same
KR101431063B1 (en) * 2012-03-08 2014-08-21 (주)바이오메디앙 Protein marker apolipoprotein c-1 for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same
CN105652019B (en) * 2016-02-22 2017-10-20 西安交通大学 A kind of autism serum polypeptide mark APOC1 A and its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08178923A (en) * 1994-12-21 1996-07-12 Cosmo Sogo Kenkyusho:Kk Immunoassay of lipoprotein or apolipoprotein
CA2249459A1 (en) 1996-03-29 1997-10-09 Dario Boffelli Amphipathic molecules as cholesterol and other lipid uptake inhibitors
AU762931B2 (en) * 1999-03-16 2003-07-10 Serex, Inc. Method and device for detection of Apo A, Apo B and the ratio thereof in saliva
IL163732A0 (en) * 2002-03-07 2005-12-18 Univ Johns Hopkins Genomic screen for epigenetically silenced tumor suppressor genes
NL1020962C2 (en) * 2002-06-28 2003-12-30 Tno Therapy and prognosis / monitoring for sepsis and septic shock.

Also Published As

Publication number Publication date
EP1664789A1 (en) 2006-06-07
CN1856707A (en) 2006-11-01
DE502004012230D1 (en) 2011-04-07
US20100159492A1 (en) 2010-06-24
JP2007506075A (en) 2007-03-15
WO2005038461A1 (en) 2005-04-28
ES2358903T3 (en) 2011-05-16
DE10343815A1 (en) 2005-04-14
EP1664789B1 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
ES2539854T3 (en) Early diagnosis and prediction based on the detection of IL-6 of systemic inflammatory response syndrome and sepsis in asymptomatic patients
WO2004058044A3 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
ATE469353T1 (en) USE OF NT-PROANP AND NT-PROBNP FOR DIAGNOSING HEART DISEASE
ATE315789T1 (en) ELISA FOR VEGF
MX2009003562A (en) Elisa for vegf.
WO2003073910A3 (en) Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
WO2003070894A3 (en) A non-invasive diagnostic test utilizing histone modification markers
ATE284701T1 (en) METHOD FOR TREATING TUMORS WHICH EXPRESS THE VASCULAR ENDOTHELIAL GROWTH FACTOR D
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE432997T1 (en) THERAPY MONITORING FOR TUMORS USING ACC133 MRNA
DE502006008028D1 (en) LIQUORDIAGNOSTIC IN VITRO METHOD FOR THE DIAGNOSIS OF DEMENTIA DISEASES AND NEUROINFLAMMATORY DISEASES
ATE283487T1 (en) METHOD FOR DIAGNOSIS OR PROGNOSIS OF AGE-RELATED MACULAR DEGENERATION
ATE441107T1 (en) ASSAY FOR MONITORING CANCER PATIENTS BASED ON LEVELS OF THE EXTRACELLULAR DOMAIN (ECD) ANALYTE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ALONE OR IN COMBINATION WITH OTHER ANALYTES, IN BODY FLUID SAMPLES
Thilo et al. Increased TRPC3 expression in vascular endothelium of patients with malignant hypertension
ATE499611T1 (en) METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I
ATE391917T1 (en) AUTOMATIC METHOD FOR THE QUANTITATIVE DETERMINATION AND MONITORING OF EXOGENEOUS HEMOGLOBIN IN WHOLE BLOOD, BLOOD PLASMA AND BLOOD SERUM
EP1162457A3 (en) Multiple coagulation test system and method of using a multiple coagulation test system
ATE494556T1 (en) METHOD FOR DIAGNOSING INFLAMMATORY DISEASES AND INFECTIONS USING LASP-1/LAP-1 DETERMINATION
ATE352039T1 (en) METHOD FOR DETERMINING THYMIDINKINASE-1 ACTIVITY AND USE THEREOF
JP2008107275A (en) Allergic dermatitis diagnostic method
AR056831A1 (en) METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
JP5535571B2 (en) Method for evaluating skin turnover and its use
RU2538644C1 (en) Method for prediction of acute pancreatitis progression following abdominal surgeries
FR2849204B1 (en) METHOD OF DETECTING PRPSC USING AMINOGLYCOSIDE FAMILY D Antibiotics for PRPSC Removal and Detection in Biological Samples
RU2374986C1 (en) Method of estimating functional state of cardio-vascular system of man